Eva Weisz

583 total citations
11 papers, 486 citations indexed

About

Eva Weisz is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Eva Weisz has authored 11 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Eva Weisz's work include Immune Cell Function and Interaction (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and NF-κB Signaling Pathways (3 papers). Eva Weisz is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and NF-κB Signaling Pathways (3 papers). Eva Weisz collaborates with scholars based in Austria, France and United States. Eva Weisz's co-authors include Veronika Sexl, Michael Freissmuth, Dagmar Stoiber, Boris Kovačic, Richard Moriggl, René G. Ott, Hartmut Beug, David T. Levy, Michaela Artwohl and Christian Schuster and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Eva Weisz

11 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Weisz Austria	10	235	212	206	78	73	11	486
Jean-Paul Rémy-Martin France	9	203 0.9×	260 1.2×	142 0.7×	47 0.6×	57 0.8×	13	493
Toshiko Yamochi Japan	8	204 0.9×	139 0.7×	161 0.8×	137 1.8×	75 1.0×	9	461
Ken-ichi Sawada Japan	9	74 0.3×	88 0.4×	214 1.0×	55 0.7×	81 1.1×	9	396
Eva Mikaelsson Sweden	8	195 0.8×	158 0.7×	242 1.2×	52 0.7×	125 1.7×	13	493
Peter Kjellén Sweden	12	88 0.4×	415 2.0×	163 0.8×	93 1.2×	174 2.4×	16	652
Sylvie Richelme France	14	166 0.7×	559 2.6×	408 2.0×	37 0.5×	34 0.5×	19	1.0k
Mahmoud Mansouri Sweden	12	79 0.3×	116 0.5×	211 1.0×	106 1.4×	159 2.2×	21	522
Abdelhafid Saci France	9	71 0.3×	175 0.8×	308 1.5×	35 0.4×	80 1.1×	10	567
Mikara Robati Australia	9	164 0.7×	162 0.8×	357 1.7×	52 0.7×	59 0.8×	11	511
John Densmore United States	10	219 0.9×	337 1.6×	154 0.7×	257 3.3×	202 2.8×	27	712

Countries citing papers authored by Eva Weisz

Since Specialization

Citations

This map shows the geographic impact of Eva Weisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Weisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Weisz more than expected).

Fields of papers citing papers by Eva Weisz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Weisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Weisz. The network helps show where Eva Weisz may publish in the future.

Co-authorship network of co-authors of Eva Weisz

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Weisz. A scholar is included among the top collaborators of Eva Weisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Weisz. Eva Weisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Zebedin, Eva, Olivia Simma, Christian Schuster, et al.. (2008). Leukemic challenge unmasks a requirement for PI3Kδ in NK cell–mediated tumor surveillance. Blood. 112(12). 4655–4664. 38 indexed citations

2.

Simma, Olivia, Eva Zebedin, Carola Schellack, et al.. (2008). Identification of an Indispensable Role for Tyrosine Kinase 2 in CTL-Mediated Tumor Surveillance. Cancer Research. 69(1). 203–211. 28 indexed citations

3.

Ott, René G., Olivia Simma, Karoline Kollmann, et al.. (2007). JunB is a gatekeeper for B-lymphoid leukemia. Oncogene. 26(33). 4863–4871. 19 indexed citations

4.

Kovačic, Boris, Dagmar Stoiber, Richard Moriggl, et al.. (2006). STAT1 acts as a tumor promoter for leukemia development. Cancer Cell. 10(1). 77–87. 127 indexed citations

5.

Farhan, Hesso, Christian Schuster, Markus Klinger, et al.. (2006). Inhibition of Xenograft Tumor Growth and Down-Regulation of ErbB Receptors by an Antibody Directed against Lewis Y Antigen. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1459–1466. 26 indexed citations

6.

Stoiber, Dagmar, Boris Kovačic, Christian Schuster, et al.. (2004). TYK2 is a key regulator of the surveillance of B lymphoid tumors. Journal of Clinical Investigation. 114(11). 1650–1658. 52 indexed citations

7.

Stoiber, Dagmar, Boris Kovačic, Christian Schuster, et al.. (2004). TYK2 is a key regulator of the surveillance of B lymphoid tumors. Journal of Clinical Investigation. 114(11). 1650–1658. 52 indexed citations

8.

Kenner, Lukas, Eva Weisz, René G. Ott, et al.. (2003). JunB inhibits proliferation and transformation in B-lymphoid cells. Blood. 102(12). 4159–4165. 68 indexed citations

9.

Sexl, Veronika, Boris Kovačic, Roland P. Piekorz, et al.. (2003). Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood. 101(12). 4937–4943. 26 indexed citations

10.

Hilber, Karlheinz, Walter Sandtner, Oliver Kudlacek, et al.. (2001). The Selectivity Filter of the Voltage-gated Sodium Channel Is Involved in Channel Activation. Journal of Biological Chemistry. 276(30). 27831–27839. 44 indexed citations

11.

Weisz, Eva, et al.. (1990). Influence of Urapidil and 8-OH-DPAT on Brain 5-HT Turnover and Blood Pressure in Rats. Journal of Cardiovascular Pharmacology. 15. S68–S74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact